Advertisement
Home 2018 November

Monthly Archives: November 2018

The first cannabis-based medication approved by the U.S. Food and Drug Administration is now available by prescription nationwide.

First FDA-Approved Cannabis Drug Now Available in U.S.

Epidiolex is a twice-daily oral solution for use in patients with two types of epileptic syndromes
A 10th child has died in an adenovirus outbreak at the Wanaque Center for Nursing and Rehabilitation in Haskell

10th Child Dies in Adenovirus Outbreak at N.J. Facility

So far, at least 27 children at the center have become ill
Another hypertension drug is being recalled due to contamination that could pose a cancer risk

Second Hypertension Drug Recalled Due to Contamination

Some lots of irbesartan being recalled due to contamination with suspected carcinogen
For adults with type 2 diabetes

Plant-Based Diets Beneficial for Adults With Type 2 Diabetes

Significant improvements observed in emotional and physical well-being, depression, quality of life, HbA1c

American Society of Nephrology, Oct. 23-28

The Annual Meeting of the American Society of Nephrology, Kidney Week 2018 Kidney Week, the annual meeting of the American Society of Nephrology,...
Patients undergoing surgery assume opioids will be most effective for postoperative pain relief

ASA: Patients Assume Post-Op Opioids Are Best for Pain Relief

Ninety-four percent of patients who believe they will receive opioids think they will be effective
For patients with early-stage cervical cancer

Minimally Invasive Sx May Up Mortality in Early Cervical Cancer

Two studies show increased mortality and reduced disease-free, overall survival versus open surgery
New guidelines have been released for the treatment of primary cutaneous melanoma

AAD Releases New Guidelines for the Tx of Cutaneous Melanoma

Guidelines recommend surgical excision as primary treatment modality, emphasize individualized care
Intensive blood pressure control and fenofibrate use in patients with type 2 diabetes who are at high risk for cardiovascular disease may increase the risk for adverse kidney events

ASN: Aggressive Control of BP, Lipids in T2DM May Up Kidney Risk

Strict BP control, fenofibrate use may increase long-term risk for adverse kidney events in T2DM patients
For patients undergoing maintenance hemodialysis

ASN: High-Dose, Proactive IV Iron Noninferior in Hemodialysis

High-dose IV iron administered proactively is noninferior to low-dose iron administered reactively